Logo

MNDR

Mobile-health Network Solutions Class A Ordinary Shares

MNDR

Mobile-health Network Solutions Class A Ordinary Shares • NASDAQ
$2.65 ▲ 0.00% (+0.00)
Market Cap $2.35 M
52w High $40.00
52w Low $1.53
Dividend Yield 0%
P/E -0.14
Volume 531.64K
Outstanding Shares 885.76K

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q2-2025 $4.276M ▼ $2.318M ▼ $-1.656M ▲ -38.726% ▲ $-0.38 ▲ $-1.675M ▲
Q4-2024 $5.437M ▼ $8.431M ▲ $-10.497M ▼ -193.061% ▼ $-22.17 ▼ $-10.455M ▼
Q2-2024 $6.644M ▲ $570.397K ▼ $-1.462M ▲ -22.001% ▲ $-0.45 ▼ $-1.029M ▲
Q4-2023 $4.887M ▲ $2.639M ▲ $-1.923M ▼ -39.358% ▲ $-0.382 ▼ $-1.918M ▼
Q2-2023 $2.988M $1.67M $-1.29M -43.172% $-0.223 $-1.276M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q2-2025 $2.573M ▼ $4.3M ▼ $1.756M ▼ $2.544M ▼
Q4-2024 $6.771M ▲ $7.951M ▲ $3.811M ▲ $4.139M ▲
Q2-2024 $2.547M ▲ $3.843M ▲ $3.789M ▼ $53.645K ▲
Q4-2023 $2.226M ▼ $3.443M ▼ $3.81M ▲ $-367.199K ▼
Q2-2023 $9.789M $10.701M $3.304M $7.397M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2025 $-1.656M ▲ $0 ▲ $0 ▲ $0 ▼ $0 ▼ $0 ▲
Q4-2024 $-7.801M $-3.203M $-67.106K $5.441M $4.482M $-3.27M
Q2-2024 $-7.801M ▼ $-3.203M ▼ $-67.106K ▼ $5.441M ▲ $4.482M ▲ $-3.27M ▼
Q4-2023 $-1.923M ▼ $-1.546M ▼ $-60.738K ▲ $-5.924M ▼ $-3.781M ▼ $-1.61M ▼
Q2-2023 $-1.29M $-703.088K $-125.264K $123.428K $-227.218K $-824.902K

Five-Year Company Overview

Income Statement

Income Statement MNDR looks like a very early‑stage business financially. Revenue reported so far is tiny, and the company is already running at a loss. That suggests the current phase is all about building the platform and technology rather than generating sizable sales. Profitability metrics point to meaningful operating and net losses relative to the small revenue base, which is common for young tech‑driven healthcare firms but still a risk: the business model and pricing are not yet proven at scale. Overall, the income statement shows promise on vision but not yet on financial performance.

Balance Sheet

Balance Sheet The balance sheet is very light, which reflects a small, emerging company. Assets are dominated by cash, with no notable debt, so the capital structure is simple and not weighed down by borrowings. However, the absolute level of assets and equity appears thin, implying only a modest financial cushion against unexpected setbacks. As MNDR pursues big-ticket investments like AI data centers, it will likely need ongoing external funding or equity raises, and its balance sheet will have to grow and strengthen over time to support its ambitions.

Cash Flow

Cash Flow Cash flow from operations is negative, which means the core business is currently consuming cash rather than generating it. There is little visible spending on long‑lived assets yet, so most of the cash usage appears tied to operating expenses such as staff, technology development, and platform scaling. This pattern is typical for a young, growth‑oriented tech platform, but it also means the company is reliant on capital markets or other funding sources to keep executing its strategy until the business turns cash‑generative. The key question going forward is how quickly operating cash burn can be reduced as revenue grows.

Competitive Edge

Competitive Edge MNDR is trying to carve out a niche in telehealth by being firmly doctor‑centric and AI‑enabled. Its platform aims to make life easier for clinicians while offering a broad range of services to patients, from virtual visits to pharmacy and community features. This creates potential network effects: more doctors attract more patients, and vice versa. The asset‑light virtual clinic model is designed for scalability. At the same time, telehealth is crowded and heavily regulated, with many well‑funded global and regional players. MNDR’s edge will depend on its ability to keep doctors engaged, maintain clinical quality and trust, and expand internationally without losing focus.

Innovation and R&D

Innovation and R&D Innovation is clearly the heart of MNDR’s story. The AI‑powered Health Operating System, automated clinical note‑taking, real‑time quality feedback tools for doctors, and the long‑term ambition of semi‑autonomous AI doctors all point to a bold technology roadmap. The planned acquisition of AI‑optimized data centers, and the move toward platform services like AI‑powered healthcare infrastructure and token‑based offerings, show an attempt to build not just an app, but a full digital health backbone. The flip side is execution risk: these projects are complex, capital‑intensive, and must comply with strict healthcare, data privacy, and safety rules across multiple countries. Success will hinge on converting this innovation pipeline into reliable, trusted products that clinicians and regulators are comfortable with.

Summary

MNDR is an ambitious, very early‑stage digital health company: financially small, loss‑making, and cash‑consuming, but with a big vision around AI‑driven telemedicine and a doctor‑first ecosystem. The current numbers suggest a business still in build‑out mode, without proof yet of strong or stable revenue growth. On the strategic side, the company is leaning heavily into AI, data centers, and platform services to differentiate itself in a competitive global telehealth market. Key things to watch going forward include: whether revenue begins to scale meaningfully, how fast cash burn is managed, how well the data center and AI initiatives are integrated, the strength of doctor and patient adoption, and how regulators respond to its AI‑in‑healthcare model. Overall, MNDR offers a high‑innovation, high‑execution‑risk profile typical of young, technology‑driven healthcare platforms.

NEWS

November 21, 2025 · 8:30 AM UTC

Mobile-health Network Solutions Signs MOU to Secure Two Malaysian AI Data Center Projects; Facilities Intended to Power Expansion of Company's AI Digital Health Platform

Read more

November 17, 2025 · 4:30 PM UTC

Mobile-health Network Solutions Co-CEO Teoh Pui Pui Increases Equity Stake Through Open Market Purchase

Read more

October 31, 2025 · 4:30 PM UTC

Mobile-health Network Solutions Reports FY2025 Results and Operational Update

Read more

October 16, 2025 · 8:30 AM UTC

Mobile-health Network Solutions and Brands For Good Unite to Champion Corporate Wellness and Doing Good

Read more

September 30, 2025 · 9:31 AM UTC

Mobile-health Network Solutions Unveils Proprietary Phi GPT, AI-Powered Health Companion

Read more